1.   Biliary lipid composition was not altered significantly but bicarbonate output was increased at all doses tested.

2.   Centrally administered neuropeptide Y caused a dose-dependent increase in bile flow that was associated with an increase in biliary bicarbonate output.

3.   Two subjects did not experience cymptoms due to acid perfusion and no increase in salivary bicarbonate output occurred.